跳至主要内容
临床试验/CTRI/2023/02/050140
CTRI/2023/02/050140尚未招募3 期

Randomized controlled clinical trial to study the efficacy of triphala kwath sac syringing and normal saline sac syringing in management of chronic dacryocystitis.

Tilak Ayurveda Mahavidyalaya1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2023年2月28日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
50
试验地点
1
主要终点
Sample size 50

研究概览

简要总结

The study will be intervened by the treatment of triphala kwath sac syringing and normal saline sac syringing to group A and group B respectively. The efficacy of the therapy will be assessed on the basis of subjective criteria for statistical analysis. Scoring will be designed according to the severity of symptoms. The subjective gradation of symptoms will be done as follows and the intensity of each symptom will be calculated before treatment, after treatment and after follow up. The effect of treatment result will be assessed in regards to clinical signs and symptoms on the basis of grading and scoring system. The signs and symptoms will be assessed by adopting the suitable scoring method.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
Not Applicable

入排标准

年龄范围
20.00 Year(s) 至 75.00 Year(s)(—)
性别
All

入选标准

  • Patients having symptoms of pain, swelling, watery discharge and congestion in eyes.

排除标准

  • Patients with acute infection in eyes.
  • Patients whose regurgitation test shows muco-purulent discharge.
  • Patients who have undergone cataract surgery within a month.

结局指标

主要结局

Sample size 50

时间窗: Sample size 50 | decrease in pain, congestion, watering and swelling of eyes.

decrease in pain, congestion, watering and swelling of eyes.

时间窗: Sample size 50 | decrease in pain, congestion, watering and swelling of eyes.

次要结局

  • Sample size 50(decrease in pain, congestion, watering and swelling of eyes.)

研究者

发起方
Tilak Ayurveda Mahavidyalaya
申办方类型
Private medical college

研究点 (1)

Loading locations...

相似试验